*Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements
GT Biopharma Reports Second Quarter 2026 Financial Results GlobeNewswire
Market data is delayed by at least 15 minutes.
    Show me  Calls  Puts  Both Options that expire in 

     No Options for GTBP


    Market data provided by News provided by